Baird Financial Group’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $14.4M | Sell |
57,287
-88,919
| -61% | -$22.1M | 0.02% | 457 |
|
|
2025
Q4 | $40.2M | Buy |
146,206
+24,603
| +20% | +$6.73M | 0.06% | 204 |
|
|
2025
Q3 | $31.9M | Sell |
121,603
-32,226
| -21% | -$7.83M | 0.05% | 265 |
|
|
2025
Q2 | $33.7M | Sell |
153,829
-11,893
| -7% | -$2.54M | 0.06% | 253 |
|
|
2025
Q1 | $37.1M | Buy |
165,722
+163,502
| +7,365% | +$45.1M | 0.07% | 226 |
|
|
2024
Q4 | $727K | Buy |
2,220
+188
| +9% | +$59.2K | ﹤0.01% | 1271 |
|
|
2024
Q3 | $610K | Buy |
2,032
+664
| +49% | +$203K | ﹤0.01% | 1311 |
|
|
2024
Q2 | $451K | Sell |
1,368
-128
| -9% | -$45.2K | ﹤0.01% | 1430 |
|
|
2024
Q1 | $592K | Buy |
1,496
+925
| +162% | +$342K | ﹤0.01% | 1326 |
|
|
2023
Q4 | $201K | Sell |
571
-418
| -42% | -$148K | ﹤0.01% | 1643 |
|
|
2023
Q3 | $371K | Sell |
989
-2,636
| -73% | -$1.02M | ﹤0.01% | 1442 |
|
|
2023
Q2 | $1.39M | Buy |
3,625
+2,169
| +149% | +$775K | ﹤0.01% | 1012 |
|
|
2023
Q1 | $504K | Sell |
1,456
-7,237
| -83% | -$2.11M | ﹤0.01% | 1314 |
|
|
2022
Q4 | $2.04M | Buy |
8,693
+998
| +13% | +$236K | 0.01% | 865 |
|
|
2022
Q3 | $1.89M | Buy |
7,695
+1,541
| +25% | +$469K | 0.01% | 851 |
|
|
2022
Q2 | $1.86M | Buy |
6,154
+1,892
| +44% | +$616K | 0.01% | 874 |
|
|
2022
Q1 | $1.75M | Buy |
4,262
+2,576
| +153% | +$1.01M | ﹤0.01% | 954 |
|
|
2021
Q4 | $791K | Sell |
1,686
-7
| -0.4% | -$3.01K | ﹤0.01% | 1290 |
|
|
2021
Q3 | $719K | Buy |
1,693
+461
| +37% | +$194K | ﹤0.01% | 1336 |
|
|
2021
Q2 | $442K | Buy |
+1,232
| New | +$407K | ﹤0.01% | 1439 |
|
|
2021
Q1 | – | Sell |
-1,332
| Closed | -$377K | – | 1734 |
|
|
2020
Q4 | $377K | Buy |
+1,332
| New | +$374K | ﹤0.01% | 1303 |
|
Other funds holding WST
VCM
VPM
GIM
